VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1824308
Sex: F
Age:
State: PA

Vax Date: 05/06/2021
Onset Date: 05/06/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 05/05/2021; Test Name: SARS-CoV-2 test; Test Result: Negative; Comments: Nasal swab test.

Allergies: Amoxicillin

Symptom List: Dysphagia, Epiglottitis

Symptoms: This is a spontaneous report from a contactable consumer (patient). A 22-year-old (non-pregnant) female patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# EW0170), at the age of 22, via an unspecified route of administration, on May 6, 2021, single dose, for COVID-19 immunisation. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified concomitant medication within two weeks prior to vaccination. The patient previously received amoxicillin on an unknown date and experienced drug allergy. Since the vaccination, patient has tested for COVID-19. On May 5, 2021, patient underwent a nasal swab test, SARS-CoV-2 test: negative. On May 6, 2021, patient experienced fever and chills for about 24 hours. Therapeutic measures taken as a result of events included Tylenol (paracetamol) from an unknown date and unknown if ongoing. The outcome of fever and chills for about 24 hours resolved on May 7, 2021. No follow-up attempts needed. No further information expected.

Other Meds:

Current Illness:

ID: 1824309
Sex: F
Age:
State: NY

Vax Date: 05/07/2021
Onset Date: 05/08/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Rash all over patients body; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 07May2021 at 11:15 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. Medical history included "5P minus" and COVID-19. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included cannabidiol (EPIDIOLEX) for an unknown indication from an unknown date and unknown if ongoing. On 08May2021 at 22:00, the patient experienced rash all over the patient's body. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the event and included treatment with over the counter cortizone itch cream (MANUFACTURER UNKNOWN). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event rash all over the patient's body was not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: EPIDIOLEX

Current Illness:

ID: 1824310
Sex: F
Age:
State: VT

Vax Date: 04/16/2021
Onset Date: 04/16/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Injection site pain; Tiredness; Headache; Muscle pain; Chills; Joint pain; Nausea; Dizziness; Felt unwell; Swollen lymph nodes; Neck and back ache; Neck and back ache; This is a spontaneous report from a non-contactable consumer, the patient. A 51-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 16Apr2021 at 15:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. The medical history included allergy to sulfa drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medications within two weeks of vaccination. On 16Apr2021 at 17:00, the patient experienced injection site pain, tiredness, headache, muscle pain, chills, joint pain, nausea, dizziness, felt unwell, swollen lymph nodes, neck and back ache. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events injection site pain, tiredness, headache, muscle pain, chills, joint pain, nausea, dizziness, felt unwell, swollen lymph nodes, neck and back ache were resolved on an unknown date in 2021. The patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0183) via an unspecified route of administration in the left arm on 07May2021 at 15:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1824311
Sex: M
Age:
State: OH

Vax Date: 05/08/2021
Onset Date: 05/09/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: My stomach hasn't felt this tight; Ridiculous amount of diarrhea; My arm hurts a bit; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 08May2021 at 13:00 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive concomitant medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09May2021 at 00:00, the patient experienced diarrhea, his arm hurt and had stomach tightness. The day after first shot, on 09May2021 at 12:52, at the time of report, the patient was experiencing a ridiculous amount of diarrhea. It wouldn't stop. It could smell his fear. The patients arm hurt a bit but it was not too terrible. His stomach hadn't felt so tight since he ate an entire box of taco bell's party pack nachos with extra jalapenos. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events ridiculous amount of diarrhea, arm hurt a bit but it was not too terrible and stomach tightness was not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1824312
Sex: F
Age:
State: IA

Vax Date:
Onset Date: 03/30/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Burning sensation in left abdomen; Hives; Blister; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unspecified date in 2021 as a single dose for COVID-19 immunisation. Medical history included breast cancer survivor and high blood pressure since unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included omeprazole (MANUFACTURER UNKNOWN) and metoprolol tartrate (MANUFACTURER UNKNOWN); from an unknown start date, for an unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200 ) via an unspecified route of administration in the right arm on 16Feb2021 as a single dose for COVID-19 immunisation and also received hydrocodone (MANUFACTURER UNKNOWN) on an unknown date and experienced drug allergy. On 30Mar2021 at 21:00, the patient experienced burning sensation in left abdomen, hives and blister. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19.. The clinical outcome of the events burning sensation in left abdomen, hives and blister was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: OMEPRAZOLE; METOPROLOL TARTRATE

Current Illness:

ID: 1824313
Sex: M
Age:
State: PA

Vax Date: 05/07/2021
Onset Date: 05/07/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: "I" had COVID in late March and it felt like "I" had it again for 24 hours.; "I" had testicular pain that came in separate occasions. One the night of and the second the day after. "My" testes felt pressure and it caused pain.; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 07May2021 at 14:30 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and prior to the vaccination, the patient was diagnosed with COVID-19 in late Mar(unspecified year). The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included fexofenadine hydrochloride (ALLEGRA) for unknown indication from unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0153) via an unspecified route of administration in the left arm on 16Apr2021 at 17:30 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. The patient had COVID-19 in late Mar(unspecified year). On 07May2021 at 22:30, the patient felt like having COVID-19 again for 24 hours. The patient experienced one weird event, testicular pain that happened in separate occasions. One the night of and the second the day after. The patient felt pressure in the testes and it caused pain. It resolved on its own within 24 hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events felt like having COVID-19 again for 24 hours, testicular pain, felt pressure in the testes and it caused pain were resolved on 08May2021 at 22:30. No follow-up attempts are needed. No further information is expected.

Other Meds: ALLEGRA

Current Illness:

ID: 1824314
Sex: F
Age:
State: NV

Vax Date: 05/08/2021
Onset Date: 05/08/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Severe body aches; Tiredness; Muscle aches; Slight fever; Headaches; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08May2021 at 15:30 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included unspecified multivitamin, ethinylestradiol, levonorgestrel (VIENVA), pseudoephedrine hydrochloride (SUDAFED) and fexofenadine hydrochloride (ALLEGRA); all for an unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Apr2021 at 15:00 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. On 08May2021 at 20:00, the patient experienced severe body aches, tiredness, muscle aches, slight fever and headaches. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe body aches, tiredness, muscle aches, slight fever and headaches were not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: VIENVA; SUDAFED [PSEUDOEPHEDRINE HYDROCHLORIDE]; ALLEGRA

Current Illness:

ID: 1824315
Sex: F
Age:
State: CA

Vax Date: 04/16/2021
Onset Date: 05/02/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Lower lip began to swell up; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 16Apr2021 at 14:30 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. Medical history included bipolar II disorder and OCD (obsessive-compulsive disorder). The patient did not have any allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included lithium (MANUFACTURER UNKNOWN), olanzapine (MANUFACTURER UNKNOWN) and lamotrigine (MANUFACTURER UNKNOWN) all for an unknown indication from an unknown date and were unknown if ongoing. On 02May2021 at 16:00, approximately two weeks after the vaccination, the patient's lower lip began to swell up. It was reported that the patient's lip ballooned up 2 times its normal size over the course of three days and then the swelling went away. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event lip swelling which included treatment with unspecified steroid cream and pills. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event lower lip began to swell up was resolved on an unknown date in May2021. No follow-up attempts are needed. No further information is expected.

Other Meds: LITHIUM; OLANZAPINE; LAMOTRIGINE

Current Illness:

ID: 1824316
Sex: M
Age:
State: IL

Vax Date: 05/05/2021
Onset Date: 05/05/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210506; Test Name: Test Result: Negative ; Comments: nasal swab

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: An hour after shot I heard a very loud ringing in my left ear that lasted a few seconds and now have gone several days with ringing in both ears much louder than I have ever had in past.; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0165) via an unspecified route of administration in the left arm on 05May2021 at 12:45 (at the age of 63-year-old) as a single dose for COVID-19 immunisation. Medical history included arthritis. The patient received concomitant medication within two weeks of vaccination, but was unspecified. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0165) via an unspecified route of administration in the left arm on 14Apr2021 at 12:45 (at the age of 63-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 05May2021 at 13:45, an hour after the vaccination, the patient experienced a very loud ringing in the left ear that lasted a few seconds and than had gone several days with ringing in both ears much louder than ever had in the past. Since the vaccination, the patient had been tested for COVID-19. On 06May2021, the patient underwent test via nasal swab test and the result was negative. The clinical outcome of the event loud ringing in left ear was not recovered at the time of this report No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1824317
Sex: F
Age:
State: OR

Vax Date: 05/04/2021
Onset Date: 05/05/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Lymph nodes under the left armpit swollen and very sore; Lymph nodes under the left armpit swollen and very sore; The area around injection site was sore; A fever; Body aches; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 04May2021 at 08:15 (at the age of 28-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 13Apr2021 at 14:00 (at the age of 28-years-old), as a single dose for COVID-19 immunisation. On 05May2021 at 05:00, at the morning following the second vaccine, the patient woke up to lymph nodes under the left armpit swollen and very sore as well as the area around injection site was sore. Later that day, the patient developed a fever and body aches that lasted for 5 hours. The swollen lymph nodes in her armpit area lasted 4 days and was very sore event after using heating pads. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the event lymph nodes very sore that included treatment using heating pads. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever and body aches was resolved on an unknown date in May2021, after the duration of five hours and lymph nodes under the left armpit swollen was resolved on 09May2021, after the duration of 4 days while that of the events lymph nodes very sore and the area around injection site was sore was resolved on an unknown date in May2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1824318
Sex: F
Age:
State: CA

Vax Date: 05/02/2021
Onset Date: 05/04/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Extreme sensitivity to caffeine.; Shakes; Heart palpitations; Mild nausea; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the left arm on 02May2021 at 16:30 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 09Apr2021 at 08:45 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. On 04May2021 at 08:45, after the second shot of vaccine, the patient experienced an extreme sensitivity to caffeine, prior to the second dose of Pfizer, the patient had a large tolerance to coffee or caffeine where she was never affected by any caffeine ingestion, within a day of her second Pfizer dose, she was extremely sensitive to caffeine, where she got shakes, heart palpitations and mild nausea after drinking less than a few sips of plain black coffee. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extremely sensitive to caffeine, shakes, heart palpitations and mild nausea were not resolved at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1824319
Sex: U
Age:
State: IN

Vax Date: 05/05/2021
Onset Date: 05/01/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Leg swelling - really noticeable 4 days after; Metallic taste; Heavy menstrual bleeding; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old patient of unknown gender received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left leg on 05May2021 at 15:15 (at the age of 52-year-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not know of any known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included paracetamol/ ibuprofen (ADVIL DUAL ACTION) for an unknown indication from an unknown date and unknown if ongoing. On 05May2021, the patient experienced metallic taste right after the shot and experienced heavy menstrual bleeding after shot. On 09May2021, the patient experienced leg swelling and was really noticeable 4 days after, which was on the day of reporting. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events metallic taste right after the shot, heavy menstrual bleeding after shot and leg swelling was administered at left leg were unknown at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: ADVIL DUAL ACTION

Current Illness:

ID: 1824320
Sex: F
Age:
State: CA

Vax Date: 05/04/2021
Onset Date: 05/05/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210505; Test Name: Body temperature; Result Unstructured Data: Test Result:103.4; Comments: High fever, reached max to 103.4

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: High fever, reached max to 103.4; Chills; Body ache; Headache; Nausea; Loss of taste; Feel of bitter taste; Dry cough; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the left arm on 04May2021 at 13:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included dust allergy and cockroach allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the left arm on 13Apr2021 at 18:45 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. On 05May2021 at 01:15, the patient experienced high fever that reached maximum to 103.4 (unspecified units), chills, body ache, headache, nausea, loss of taste, feel of bitter taste and dry cough. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events which included treatment with paracetamol (TYLENOL). The clinical outcome of the events high fever that reached maximum to 103.4 (unspecified units), chills, body ache, headache, nausea, loss of taste, feel of bitter taste and dry cough was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1824321
Sex: F
Age:
State:

Vax Date: 05/04/2021
Onset Date: 05/05/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: My period came a week early the day after my 2nd dose of the vaccine.; This is a spontaneous report from a non-contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 04May2021 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 05May2021, the day after 2nd dose of the vaccine, the patient's period came a week early. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event period came a week early the day after 2nd dose of the vaccine was unknown at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1824322
Sex: F
Age:
State: RI

Vax Date: 05/08/2021
Onset Date: 05/08/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Left underarm lymph node is swollen and painful; Fatigue; Underarm lymph node is swollen and painful; Feverish; Pounding headache; Mild stomach discomfort; Chills; Body aches; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the left arm on 08May2021 at 10:15 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient was allergic to shellfish. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included vitamin d (MANUFACTURER UNKNOWN), multivitamins (MANUFACTURER UNKNOWN) and calcium chews (MANUFACTURER UNKNOWN); all medications for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 17Apr2021 at 10:15 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. On 08May2021 at 22:15, 12 hours after second vaccine, the patient experienced chills and body aches. On 09May2021, at 01:15, the patient experienced feverish, pounding headache and mild stomach discomfort. On 09May2021, at 16:00, the patient experienced left underarm lymph node is swollen, painful and fatigue. The events did not result in doctor or other healthcare professional office, clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events chills, body aches, feverish, pounding headache, mild stomach discomfort, left underarm lymph node is swollen and painful and fatigue. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event feverish was resolved on 09May2021 while that of the events chills, body aches, pounding headache, mild stomach discomfort, left underarm lymph node is swollen and painful and fatigue were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: VITAMIN D [VITAMIN D NOS]; CALCIUM

Current Illness:

ID: 1824323
Sex: F
Age:
State: NY

Vax Date: 05/04/2021
Onset Date: 05/05/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Body ache; Fever; Headaches; Tiredness; Itching (full body); This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179) via an unspecified route of administration in the left arm on 04May2021 at 17:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included unknown allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within 2 weeks of vaccination. On 05May2021, the patient experienced body ache for 2 days, fever for 1 day, headaches for 4 days, tiredness for 4 days and itching (full body) for 1 day. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever and itching (full body) was resolved on 06May2021; body ache was resolved on 07May2021 while headaches and tiredness was resolving at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1824324
Sex: M
Age:
State: FL

Vax Date: 03/28/2021
Onset Date: 04/01/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data: Test Date: 202104; Test Name: Blood work; Result Unstructured Data: Test Result:Absolute eosinophils counts are low; Test Date: 202104; Test Name: Blood work; Result Unstructured Data: Test Result:Absolute lymphocytes and absolute eosinophils c...; Comments: Absolute lymphocytes and absolute eosinophils counts are low

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Absolute lymphocytes and absolute eosinophils counts are low; Absolute lymphocytes and absolute eosinophils counts are low; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 28Mar2021 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not did not receive any medications within two weeks prior to the COVID-19 vaccine. On an unknown date in Apr2021, the patient experienced absolute lymphocytes and absolute eosinophils counts are low. The patient reported that, according to a recent blood work conducted 3 weeks after the second dose, her absolute lymphocytes and absolute eosinophils counts were low. On an unknown date in Apr2021, the patient underwent blood work absolute lymphocytes and absolute eosinophils counts and the results were low count. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event's absolute lymphocytes and absolute eosinophils counts are low were unknown. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1824325
Sex: M
Age:
State: GA

Vax Date: 04/30/2021
Onset Date: 05/03/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Ringing in ears; This is a spontaneous report from a non-contactable consumer, the patient. A 62-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew01658/21) via an unspecified route of administration in the left arm on 30Apr2021 at 18:00 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. The patient did not have medical history and known allergies. Prior to vaccination, the patient was not diagnosed with COVID -19. Concomitant medication was not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03May2021, the patient experienced ringing in ears. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event ringing in ears was not resolved at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1824326
Sex: F
Age:
State: WI

Vax Date: 05/07/2021
Onset Date: 05/08/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Severe fatigue; Chills; Headache; Swollen lymph node on the left side of my neck; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 07May2021 at 11:00 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergies to latex. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included quetiapine (MANUFACTURER UNKNOWN) 50 mg , cetirizine hydrochloride (WAL ZYR) 10 mg and famotidine (MANUFACTURER UNKNOWN) 40 mg; all taken for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: GR8731) via an unspecified route of administration in the left arm on 16Apr2021 at 11:00 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. The patient previously received aspartame (MANUFACTURER UNKNOWN) for unknown indication and experienced drug allergy. On 08May2021 at 08:00, the patient experienced severe fatigue, chills, headache and swollen lymph node on the left side of her neck. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe fatigue, chills, headache and swollen lymph node on the left side of her neck were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: QUETIAPINE; WAL ZYR; FAMOTIDINE

Current Illness:

ID: 1824327
Sex: F
Age:
State: IL

Vax Date: 04/22/2021
Onset Date: 04/24/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Symptoms similar to what "I" experienced when "I" had COVID. Hot flashes with high frequencies; Feel nauseated; Severe headache; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 22Apr2021, at 09:00 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19.Patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications included hyaluronic acid/glucosamine sulfate/gelatine hydrolysate/ chondroitin sulfate sodium (GLUCOSAMINE CHONDROITIN), amoxicillin (MANUFACTURER UNKNOWN) and collagen (MANUFACTURER UNKNOWN); all for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Apr2021, at 02:00 the patient experienced symptoms similar to what she experienced when she had COVID, hot flashes with high frequencies, that made her feel nauseated and severe headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events hot flashes with high frequencies, that made the patient feel nauseated and severe headache were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: GLUCOSAMINE CHONDROITIN [CHONDROITIN SULFATE SODIUM;GELATINE HYDROLYSATE;GLUCOSAMINE SULFATE;HYALURO; AMOXICILLIN; COLLAGEN

Current Illness:

ID: 1824328
Sex: F
Age:
State: OR

Vax Date: 05/04/2021
Onset Date: 05/07/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Swollen lymph node on left collar bone. It is very painful; Swollen lymph node on left collar bone. It is very swollen; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO0118) via an unspecified route of administration in the left arm on 04May2021 at 12:45 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine sodium (SYNTHROID) for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EW0153) via an unspecified route of administration in the left arm on 06Apr2021 at 18:15 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. On 07May2021 at 12:00, the patient experienced swollen lymph node on left collar bone and it was very painful and swollen. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swollen lymph node on left collar bone and it was very painful and swollen was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: SYNTHROID

Current Illness:

ID: 1824329
Sex: M
Age:
State: KY

Vax Date: 05/05/2021
Onset Date: 05/06/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 2021; Test Name: Antigen test; Test Result: Negative ; Comments: nasal swab

Allergies:

Symptom List: Unevaluable event

Symptoms: Nausea; Headache; Extreme weakness/ So weak; Dizziness/ dizzy; Fast heart beat (sometimes wake me from sleep); Difficulty breathing; Sore at injection site; Sore muscles and joints; Sore muscles and joints; Chills; Fever; Swollen under arm Lymph node on same side as injection; One time vomiting (possibly unrelated to vaccine); Some diarrhea; Pain in kidney areas, sometimes left side, some time both sides; General feeling sick; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 05May2021 at 14:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and allergy to penicillin. Concomitant medications included montelukast (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14Apr2021 at 14:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. On 06May2021 at 05:30, the patient experienced nausea, headache, extreme weakness, dizziness, fast heartbeat (sometimes woke the patient from sleep), difficulty breathing, sore at injection site, sore muscles and joints, chills, fever, general feeling sick, swollen under arm lymph node on same side as injection, one time vomiting (possibly unrelated to vaccine), some diarrhea, pain in kidney areas, sometimes left side, sometime both sides, so weak and dizzy that he had to miss two days of work and too dizzy to drive. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On an unknown date in 2021, the patient underwent antigen test via nasal swab and the result was negative. The clinical outcome of the events nausea, headache, extreme weakness/so weak, dizziness/dizzy, fast heartbeat (sometimes woke the patient from sleep), difficulty breathing, sore at injection site, sore muscles and joints, chills, fever, general feeling sick, swollen under arm lymph node on same side as injection, one time vomiting (possibly unrelated to vaccine), some diarrhea and pain in kidney areas, sometimes left side, sometime both sides was resolving at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds: MONTELUKAST

Current Illness:

ID: 1824330
Sex: M
Age:
State: UT

Vax Date: 04/30/2021
Onset Date: 05/07/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Ringing in my ears ( Tinnitus); This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 30Apr2021 at 14:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0130) via an unspecified route of administration in the left arm on 09Apr2021 at 13:15 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. On 07May2021, the patient experienced ringing in his ears (tinnitus). The event did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event ringing in his ears (tinnitus) was not resolved at the time of report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1824331
Sex: M
Age:
State: OR

Vax Date: 05/06/2021
Onset Date: 05/06/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Right armpit pain on the side of my chest; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 06May2021 at 12:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to vaccination, the patient was not diagnosed with COVID -19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included amfetamine aspartate/ amfetamine sulfate/dexamfetamine saccharate/dexamfetamine sulfate (ADDERALL) used for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 08Apr2021 at 12:15 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. On 06May2021 at 20:00, the patient experienced right armpit pain on the side of the chest. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event right armpit pain on the side of the chest. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event right armpit pain on the side of the chest was not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: ADDERALL

Current Illness:

ID: 1824332
Sex: M
Age:
State: CA

Vax Date: 05/04/2021
Onset Date: 05/04/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Sore joints; Sore injection site; Large amount Fatigue; Migraine; Headache; Brain fog; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 04May2021 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 07Apr2021 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. On 04May2021, the patient experienced sore joints. sore injection site, large amount fatigue, migraine, headache, brain fog, and nausea. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore joints, sore injection site, large amount fatigue, migraine, headache, brain fog, and nausea were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1824333
Sex: F
Age:
State: OK

Vax Date: 05/06/2021
Onset Date: 05/08/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Swelling in neck; Swelling in underarm glands; Swelling on the outer part of of left breast; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 06May2021 at 14:30 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medications. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 13Apr2021 at 14:30 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. On 08May2021 at 21:30, the patient experienced swelling in neck and underarm glands and swelling on the outer part of left breast. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the events swelling in neck and underarm glands and swelling on the outer part of left breast was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1824334
Sex: F
Age:
State:

Vax Date: 04/19/2021
Onset Date:
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210503; Test Name: SARS CoV-2 test; Test Result: Negative

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Whole body ached; pain in my hands; pain in my hands resulting in me not being able to hold a pen for any amount of time; This is a spontaneous report from a non-contactable consumer, the patient. A 28-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Apr2021 at 17:30 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021 the patient experienced whole body ache and pain in hands resulting in not being able to hold a pen for any amount of time. Pain in hands relapsed 2 weeks after the vaccine. The events resulted in emergency room/department or urgent care. Therapeutic measures were taken as a result of adverse events and included treatment with paracetamol (TYLENOL) and Naproxen (MANUFACTURER UNKNOWN) twice daily. Since the vaccination the patient had not been tested for COVID-19. On 03May2021, the patient underwent nasal swab, SARS CoV-2 test and the result was negative. The clinical outcome of the events whole body ache and pain in hands resulting in not being able to hold a pen for any amount of time, pain in hands relapsed 2 weeks after the vaccine were resolving at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1824335
Sex: M
Age:
State: PA

Vax Date: 05/07/2021
Onset Date: 05/08/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Headache; Chills; Fever; Sore throat; Post nasal drip; Coughing; Sneezing; This is a spontaneous report from a contactable healthcare professional, the patient. A 39-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the right arm on 07May2021 at 14:15(at the age of 39-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not take any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the right arm on 13Apr2021 at 14:15 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. On 08May2021, the patient experienced headache, chills, fever, sore throat, post nasal drip, coughing and sneezing. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, chills, fever, sore throat, post nasal drip, coughing and sneezing were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1824336
Sex: F
Age:
State: CA

Vax Date: 04/02/2021
Onset Date: 04/03/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 02Apr2021 at 10:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medications. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 03Apr2021, the patient experienced severe rash on ankles. The events did not result in doctor/other health care professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the event. The clinical outcome of severe rash on ankles was recovering at the time of this report. The patient also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 23Apr2021 at 10:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1824337
Sex: F
Age:
State: NC

Vax Date: 04/21/2021
Onset Date: 04/24/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: About 3 days after the vaccine, I started having random bloody noses; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW 0170) via an unspecified route of administration in the right arm on 21Apr2021 at 16:30 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, allergies, bloody noses and known allergies to latex, various foods, molds, pollens, etc. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included cetirizine hydrochloride (ZYRTEC), montelukast sodium (SINGULAIR), citalopram (MANUFACTURER UNKNOWN), fluticasone propionate/salmeterol xinafoate (ADVAIR) and vitamin d nos (MANUFACTURER UNKNOWN); all for unknown indication from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 24Apr2021, about 3 days after the vaccine, the patient experienced random bloody noses for about a week. For about a week, the patient had around 2 per day and now she had one every few days. The patient reported that prior to the vaccine, bloody noses were very very rare. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events random bloody noses for about a week, she had around 2 per day and now had one every few days was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ZYRTEC [CETIRIZINE HYDROCHLORIDE]; SINGULAIR; CITALOPRAM; ADVAIR; VITAMIN D NOS

Current Illness:

ID: 1824338
Sex: F
Age:
State: OR

Vax Date: 05/07/2021
Onset Date: 05/07/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: 3 bad bloody noses 48 hours of vaccination; Extreme tiredness; Loss of appetite; Fever; This is a spontaneous report from a contactable consumer, the patient. A 21-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0182) via an unspecified route of administration in the left arm on 07May2021 at 14:00 (at the age of 21-year-old), as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included ethinylestradiol/ferrous fumarate/norethisterone acetate (JUNEL FE) for birth control from an unknown date and unknown if ongoing. The patient previously received amoxicillin/ clavulanate potassium (AUGMENTIN) for unspecified indication from unknown date and experienced drug allergy. On 07May2021 at 19:00, the patient experienced 3 bad bloody noses in 48 hours of vaccination, extreme tiredness, loss of appetite and fever. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extreme tiredness, loss of appetite, fever and 3 bad bloody noses was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: JUNEL FE

Current Illness:

ID: 1824339
Sex: F
Age:
State: PA

Vax Date: 04/05/2021
Onset Date: 04/07/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Swollen Lymph nodes thought-out mu entire body. Under left and arm are the worst with my stomach area being the second worst area; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9266) via an unspecified route of administration in the left arm on 05Apr2021 at 09:30 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included blood clot in spline in Jan2021 and allergy to sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included apixaban (ELIQUIS), metformin (MANUFACTURER UNKNOWN), calcium citrate (CITRACAL), magnesium (MANUFACTURER UNKNOWN) and cetirizine hydrochloride (ZYRTEC); all for unknown indication from an unknown date and unknown if ongoing. The patient previously received neomycin (MANUFACTURER UNKNOWN) and oxybutynin (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL8982) via an unspecified route of administration in the left arm on 15Mar2021 at 09:00 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. On 07Apr2021 at 11:00, the patient experienced swollen lymph nodes thought-out her entire body. Under left and arm was the worst with stomach area being the second worst area. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event swollen lymph nodes thought-out her entire body; under left and arm was the worst with stomach area being the second worst area was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ELIQUIS; METFORMIN; CITRACAL [CALCIUM CITRATE]; MAGNESIUM; ZYRTEC [CETIRIZINE HYDROCHLORIDE]

Current Illness:

ID: 1824340
Sex: F
Age:
State: OH

Vax Date: 05/07/2021
Onset Date: 05/08/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Extreme fatigue; Slight headache (2/10); Painful lymphadenopathy in left axilla; This is a spontaneous report from a contactable healthcare professional, the patient. A 25-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07May2021 at 14:30 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. The medical history included GERD (gastroesophageal reflux disease) and allergy to sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The concomitant medications included pantoprazole sodium sesquihydrate (PROTONIX) for an unspecified indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Apr2021 at 16:00 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. On 08May2021 at 12:00, the patient experienced extreme fatigue, slight headache (2/10) and painful lymphadenopathy in left axilla. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extreme fatigue, slight headache (2/10) and painful lymphadenopathy in left axilla were resolving at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: PROTONIX [PANTOPRAZOLE SODIUM SESQUIHYDRATE]

Current Illness:

ID: 1824341
Sex: M
Age:
State: MO

Vax Date: 05/04/2021
Onset Date: 05/01/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210505; Test Name: Body temperature; Result Unstructured Data: Test Result:99.7; Test Date: 20210504; Test Name: Body temperature; Result Unstructured Data: Test Result:96.8

Allergies:

Symptom List: Tremor

Symptoms: 4 hours later in the morning "my" temperature was 99.7; All "my" bones and muscles were aching; All "my" bones and muscles were aching; Within 2 hours of receiving "my" second dose of vaccine "I" started getting headache; General body ache; That night "I" woke after 3hours of sleep feeling cold and checking "my" temperature it was 96.8; And now a week later "I" still hurt in my joints. It isworry some and painful.; This is a spontaneous report from a contactable consumer, the patient. A male patient of (18-64 Years) unspecified age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 04May2021 at 13:15 as a single dose for COVID-19 immunisation. Medical history was not report. The patient had known allergies to aspirin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included certalene (MANUFACTURER UNKNOWN) for unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 10Apr2021 at 13:15 as a single dose for COVID-19 immunisation. On 04May2021 at 15:30 (reported as within 2 hours), the patient experienced getting headache and general body ache. On the same day at night, he woke up after 3 hours of sleep feeling cold and checking his body temperature which was found to be 96.8 (units unspecified). On 05May2021, 4 hours later in the morning, the patient again checked his body temperature test and result was found to be 99.7 (units unspecified). On the same day, the patient also experienced all his bones and muscle were aching. The patient reported that he checked to see if he should be alarm and found out the second dose does cause some reactions. The patient also reported that 48 hours after the shot most of his aches subsided but bone aches persisted. On an unknown date in May2021, the patient also experienced joint ache which were still hurting a week later and were worry some and painful. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of headache, generalised aching, feeling cold, body temperature increased, bone pain, muscle ache and joint pain and included treatment with ibuprofen (MANUFACTURER UNKNOWN). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache and general body ache, feeling cold, body temperature increased, bone pain and muscle pain were recovered/resolved with sequelae; whereas joint pain was not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1824342
Sex: F
Age:
State: MD

Vax Date: 05/06/2021
Onset Date: 05/08/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Raised rash all over body; Raised rash all over body. Hot and very itchy. Raised rash all over body. Hot and very itchy. This is a spontaneous report from a contactable other healthcare professional, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 06May2021 at 07:45 (at the age of 42-year-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 15Apr2021 at 12:45 (at the age of 42-year-old), as a single dose for COVID-19 immunisation. On 08May2021, the patient had raised rash all over body, hot and very itchy. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events raised rash all over body and hot and very itchy was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1824343
Sex: F
Age:
State: NJ

Vax Date: 04/26/2021
Onset Date: 04/28/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: acute tonsillitis; First symptoms were various lumps on my face and neck, which have not dissipated. The first were by my lips and on my chin, followed by my neck and jawline.; severe sore throat; This is a spontaneous report from a non-contactable consumer or other non healthcare professional. A 53 year old non pregnant female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Left on 26Apr2021 (Batch/Lot Number: CW0167) as DOSE 2, SINGLE for covid-19 immunisation. Historical vaccine included bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on Mar2021 (Batch/Lot Number: ER3737) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included colitis ulcerative from an unknown date and unknown if ongoing , hypertension from an unknown date and unknown if ongoing Controlled , covid-19 from an unknown date and unknown if ongoing , drug hypersensitivity from an unknown date and unknown if ongoing. Concomitant medication(s) included losartan (LOSARTAN) taken for an unspecified indication, start and stop date were not reported; amlodipine besilate (AMLODIPINE BESILATE) taken for an unspecified indication, start and stop date were not reported; mesalamine (MESALAMINE) taken for an unspecified indication, start and stop date were not reported. The patient experienced first symptoms were various lumps on the face and neck, which have not dissipated. the first were by the lips and on the chin, followed by the neck and jawline. on 28Apr2021 08:00 with outcome of not recovered , severe sore throat causing oropharyngeal pain on 28Apr2021 08:00 with outcome of not recovered, acute tonsillitis on 07May2021 02:30 with outcome of not recovered. Therapeutic measures were taken as a result of severe sore throat and acute tonsillitis by taking Advil cold & sinus and gargling with hot salt water and antibiotics Follow-up (11May2021): This is a follow-up spontaneous report from a non-contactable consumer. This consumer reported that: No follow-up attempts are possible. No further information is expected.

Other Meds: LOSARTAN; AMLODIPINE BESILATE; MESALAMINE

Current Illness:

ID: 1824344
Sex: F
Age:
State: TX

Vax Date: 05/03/2021
Onset Date: 05/07/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: My right big toe started curling upward and stuck there for 5 long scary minutes. All my leg muscles are fine, I could feel except my bended right big toe. Never ever I eas able to flex backward only; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 59267100001) via an unspecified route of administration in the left arm on 03May2021 at 15:15 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergies to penicillin. The patient was healthy. Prior to the vaccination, the patient was not diagnosed with COVID-19. It was unknown if the patient received any other vaccines within four weeks prior to the vaccination. Concomitant medication was not reported. On 07May2021 at 20:30, the patient experienced her right big toe started curling upward and stuck there for 5 long scary minutes, all her leg muscles were fine, could feel except her bended right big toe, never ever was able to flex backward only one big toe, other toes were fine. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events reported. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events her right big toe started curling upward and stuck there for 5 long scary minutes. All her leg muscles were fine, she could feel except her bended right big toe. Never ever she was able to flex backward only one big toe, other toes were fine was resolved on an unknown date in May2021. No follow-up attempts needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1824345
Sex: F
Age:
State: NJ

Vax Date: 05/07/2021
Onset Date: 05/07/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Headache; Fever; Sore arm; Tight chest; Swollen lymph nodes; Exhausted; Shortness of breath; Sore throat; Ear ache; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 07May2021 at 12:00 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 07May2021 at 16:45, the patient experienced headache, fever, sore arm, tight chest, swollen lymph nodes, exhausted, shortness of breath, sore throat and ear ache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, fever, sore arm, tight chest, swollen lymph nodes, exhausted, shortness of breath, sore throat and ear ache was resolving at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1824346
Sex: F
Age:
State: MI

Vax Date: 05/01/2021
Onset Date: 05/01/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210501; Test Name: Body temperature; Result Unstructured Data: Test Result:104; Test Date: 202105; Test Name: Body temperature; Result Unstructured Data: Test Result:102.3; Test Date: 20210501; Test Name: Body temperature; Result Unstructured Data: Test Result:102.9; Comments: fever went up to 102.9 and it kept going up all day until it reached 104

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: After 2 hours of the vaccine, ''my'' fever went up to 102.9 and it kept going up all day until it reached 104./ a fever of 102.3; After 2 weeks exactly of ''my'' 2nd dose, ''I'' feel very fatigue; No energy at all; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 01May2021 at 10:45 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medications. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 01May2021, after 2 hours of the vaccine, the patient experienced fever which went up to 102.9 and it kept going up all day until it reached 104. On an unknown date in May2021, after 2 weeks exactly of her second dose, the patient felt very fatigue, no energy at all, diarrhea and a fever of 102.3. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever went up to 102.9 and it kept going up all day until it reached 104. After 2 weeks exactly of her second dose, the patient felt very fatigue, no energy at all, diarrhea and a fever of 102.3 was unknown at the time of this report No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1824347
Sex: M
Age:
State: CT

Vax Date: 02/01/2021
Onset Date: 02/01/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: This is a spontaneous report from a contactable consumer. A 85-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in Feb2021 (at the age of 85-years-old) as a single dose for COVID-19 immunisation. Medical history included stage 1 prostate cancer. Prior to the vaccination, it was unknown whether the patient was diagnosed with COVID-19. Concomitant medications included unspecified medication for stage 1 prostate cancer from an unknown date and unknow if ongoing. It was unknown whether the patient received any other vaccines within four weeks prior to the COVID vaccine. On an unknown date in Feb2021, the patient experienced pain in upper arms. The event pain in upper arms did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown if the patient received any treatment for the event. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the event pain in upper arms was unknown at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1824348
Sex: F
Age:
State: MI

Vax Date: 05/07/2021
Onset Date: 05/08/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Nausea; upset stomach; chills; headache; dizziness; trouble sleeping; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07May2021 at 08:15 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included post-traumatic stress disorder (PTSD) with anxiety panic attacks and migraines. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications taken within two weeks of vaccination included melatonin (MANUFACTURER UNKNOWN), omeprazole (MANUFACTURER UNKNOWN), venlafaxine (MANUFACTURER UNKNOWN), alprazolam (XANAX) and cetirizine hydrochloride (ZYRTEC); all for an unknown indication from an unknown date and unknown if ongoing. The patient previously took gabapentin (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and experienced drug allergy. On 08May2021 at 02:30, the patient experienced nausea, upset stomach, chills, headache, dizziness and had trouble sleeping. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events nausea, upset stomach, chills, headache, dizziness and trouble sleeping was resolved on an unknown date in May2021. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: MELATONIN; OMEPRAZOLE; VENLAFAXINE; XANAX; ZYRTEC [CETIRIZINE HYDROCHLORIDE]

Current Illness:

ID: 1824349
Sex: F
Age:
State: NJ

Vax Date: 04/05/2021
Onset Date: 04/09/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Ringing in ears sometimes louder in the left ear -vaccine in left arm; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 05Apr2021 at 14:15 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took codeine (MANUFACTURER UNKNOWN) and experienced drug allergy. On 09Apr2021 at 16:00, the patient experienced ringing in ears sometimes louder in the left ear. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of event and included ENT visit and hearing test was scheduled. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event ringing in ears sometimes louder in the left ear was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1824350
Sex: M
Age:
State: MA

Vax Date: 04/20/2021
Onset Date: 04/27/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: I started getting a specific very unpleasant metallic smell (and to a lesser degree taste) to pistachios, peanut butter and to a lesser degree, almond butter.; I started getting a specific very unpleasant metallic smell (and to a lesser degree taste) to pistachios, peanut butter and to a lesser degree, almond butter.; I also notice the same smell in my body odor and feces; I also notice the same smell in my body odor and feces (which may be related to eating the above objects). These may be related in the sense that they are all dry roasted; This is a spontaneous report from a contactable physician, the patient. A 47-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 20Apr2021 at 17:30 at the age of 47-years-old as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications were not reported. On 27Apr2021, the patient started getting a specific very unpleasant metallic smell to pistachios, peanut butter, and to a lesser degree, almond butter. The patient also noticed the same smell in his body odor and feces. These might be related in the sense that they were all dry roasted. He had looked at vaccine smell changes, and the best he could found was that changes in smell resolved after a few days. But mined had not diminished at all. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events specific very unpleasant metallic smell (and to a lesser degree taste) to pistachios, peanut butter, and to a lesser degree, almond butter, and also noticed the same smell in his body odor and feces was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1824351
Sex: M
Age:
State: SC

Vax Date: 04/17/2021
Onset Date: 04/19/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210420; Test Name: Nasal swab; Result Unstructured Data: Test Result:Negative

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Loss of taste and smell; Loss of taste and smell; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 17Apr2021 at 10:00 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified concomitant medications within two weeks of vaccination. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 19Apr2021, the patient experienced the loss of taste and smell for 2 days 3 days after receiving the vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On 20Apr2021, the patient underwent COVID-19 test via nasal swab and the result found to be negative. The clinical outcome of the events loss of taste and smell was resolved on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1824352
Sex: F
Age:
State: MA

Vax Date: 04/01/2021
Onset Date: 05/06/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: I developed sores on my tongue and in my mouth; I developed sores on my tongue and in my mouth; Swollen and painful glands; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the right arm on an unknown date in Apr2021 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to penicillin (PCN), mycins and sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient received unspecified concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the right arm on 01Apr2021 at 08:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. On 06May2021, two weeks after the second dose, the patient developed with sores on her tongue and in her mouth, along with swollen and painful glands. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sores on her tongue and in her mouth, along with swollen and painful glands were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1824353
Sex: F
Age:
State: TX

Vax Date: 02/25/2021
Onset Date: 03/12/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Major change in the monthly cycle after 25+ years of cycle routine. Major PMS enhancement; Major PMS enhancement.; A normal headache changed to major migraines and cramping for each cycle since the Vaccine.; A normal headache changed to major migraines and cramping for each cycle since the Vaccine.; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an intramuscular route of administration in the left arm on 25Feb2021 at 12:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient included was allergic to sulfa drugs. The patient did not take any concomitant medications. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9269) via an intramuscular route of administration in the left arm on 04Feb2021 at 15:15 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. On 12Mar2021, the patient experienced major change in the monthly cycle after 25 plus years of cycle routine, major PMS enhancement. A normal headache changed to major migraines and cramping for each cycle since the vaccine. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events major change in the monthly cycle after 25 plus years of cycle routine, major PMS enhancement. A normal headache changed to major migraines and cramping for each cycle since the vaccine. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events major change in the monthly cycle after 25 plus years of cycle routine, major PMS enhancement was, a normal headache changed to major migraines and cramping for each cycle since the vaccine was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1824354
Sex: F
Age:
State: CO

Vax Date: 05/04/2021
Onset Date: 05/04/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Left armpit and shoulder swelled significantly; Left armpit and shoulder swelled significantly; Lymph nodes were painful to movement or touch; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 04May2021 at 18:30 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history (reported as not applicable (n/a)) and known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included unspecified birth control medication (MANUFACTURER UNKNOWN) from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 13Apr2021 at 14:30 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. On 04May2021 at 23:30, after second dose, the patient's left armpit and shoulder swelled significantly and lymph nodes were painful to movement or touch and reported that took several days for swelling to subside. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events left armpit and shoulder swelled significantly and lymph nodes were painful to movement or touch was resolving at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1824355
Sex: F
Age:
State: CA

Vax Date: 04/22/2021
Onset Date: 04/23/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Swelling under arm and on my side 24 hours after the injection. Not at injection site, but under the arm and in the armpit; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 22Apr2021, at 11:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. The patient did not have any other relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Apr2021, at 11:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. On 23Apr2021, 24 hours after the injection, the patient experienced swelling under arm and on her side and not at injection site, but under the arm and in the armpit, with no fever. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event 24 hours after the injection, the patient experienced swelling under arm on side and not at injection site, but under the arm and in the armpit was resolved on 27Apr2021, which was lasted for 4days. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1824356
Sex: F
Age:
State: TX

Vax Date: 03/25/2021
Onset Date: 04/01/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Felt squeezing pressure up and down left arm for several days; Felt pain/pressure on back left side of shoulder; Felt pain/pressure on back left side of shoulder and on arm; Tingling/numbness in left hand; Tingling/numbness in left hand; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 25Mar2021 at 12:15 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included West Nile virus with encephalitis, endometriosis, Epstein-Barr. The patient was allergic to onions and milk products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive other vaccines within four weeks prior to the vaccination. Concomitant medications included acyclovir (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 04Mar2021 at 11:15 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. On 09Apr2021, after the 2nd shot, the patient felt squeezing pressure up and down left arm for several days. A week or so after that stopped, on an unknown date in Apr2021, the patient felt pain/pressure on the back left side of the shoulder and on the arm and tingling/numbness in the left hand which was still going and was 24 by 7. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events felt squeezing pressure up and down left arm was resolved with sequelae on an unknown date in Apr2021. The clinical outcome of the events felt pain/pressure on back left side of shoulder and on arm, tingling/numbness in left hand were not recovered at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: ACYCLOVIR [ACICLOVIR]

Current Illness:

ID: 1824357
Sex: F
Age:
State: OH

Vax Date: 04/27/2021
Onset Date: 04/27/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Stiffness in my neck on my right side; Unusual sensation start up through my neck/ below my ear in my gland area and into my jaw line/ slightly numb but not totally numb; This is a spontaneous report from a contactable pharmacist, the patient. A 45-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the right arm on 27Apr2021 at 10:30 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included thyroid lobectomy on May 2019 as a result of a follicular neoplasm which was identified post op as malignant. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), levonorgestrel (MIRENA) and beta glucan (WELLMUNE); all from an unknown date for unknown indication and unknown if ongoing. On 27Apr2021 at 10:45 (also reported approximately 6 minutes post vaccine), the patient started to notice stiffness in neck on right side, same side as vaccine shot. At first, patient thought it was just from a workout the day previous but then had an unusual sensation start up through her neck, below her ear in her gland area and into her jaw line. The patient reported that she would describe it similar to the sensation post being to the dentist as an anesthetic was wearing off and she experienced slightly numb but not totally numb. The patient stated that, it never got worse over the course of the day and wasn't bad enough to warrant to seek medical treatment. The patient further stated that, it took 48-72 hours to fully clear. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event stiffness in my neck on my right side and unusual sensation start up through my neck, below the ear in the gland area and into my line, slightly numb but not totally numb were resolved on an unspecified date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: LEVOTHYROXINE; MIRENA; WELLMUNE

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am